Similar articles

• Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.

  Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, Frese KK, Denicola G, Feig C, Combs C, Winter SP, Ireland-Zecchini H, Reichelt S, Howat WJ, Chang A, Dhara M, Wang L, Rückert F, Grützmann R, Pilarsky C, Izeradjene K, Hingorani SR, Huang P, Davies SE, Plunkett W, Egorin M, Hruban RH, Whitebread N, McGovern K, Adams J, Iacobuzio-Donahue C, Griffiths J, Tuveson DA. Olive KP, et al. Science. 2009 Jun 12;324(5933):1457-61. doi: 10.1126/science.1171362. Epub 2009 May 21. Science. 2009. PMID: 19460966 Free PMC article.
• Hedgehog pathway inhibition and the race against tumor evolution.

  Atwood SX, Chang AL, Oro AE. Atwood SX, et al. J Cell Biol. 2012 Oct 15;199(2):193-7. doi: 10.1083/jcb.201207140. J Cell Biol. 2012. PMID: 23071148 Free PMC article.
• Hedgehog- and mTOR-targeted therapies for advanced basal cell carcinomas.

  Piérard-Franchimont C, Hermanns-Lê T, Paquet P, Herfs M, Delvenne P, Piérard GE. Piérard-Franchimont C, et al. Future Oncol. 2015 Nov;11(22):2997-3002. doi: 10.2217/fon.15.181. Epub 2015 Oct 5. Future Oncol. 2015. PMID: 26437034 Review.
• Identification and structure-activity relationships of ortho-biphenyl carboxamides as potent Smoothened antagonists inhibiting the Hedgehog signaling pathway.

  Peukert S, Jain RK, Geisser A, Sun Y, Zhang R, Bourret A, Carlson A, Dasilva J, Ramamurthy A, Kelleher JF. Peukert S, et al. Bioorg Med Chem Lett. 2009 Jan 15;19(2):328-31. doi: 10.1016/j.bmcl.2008.11.096. Epub 2008 Dec 3. Bioorg Med Chem Lett. 2009. PMID: 19091559
• Advances in Smoothened-targeting therapies for pancreatic cancer: implication for drug discovery from herbal medicines.

  Han JB, Hua YQ, Chen LY, Liu LM. Han JB, et al. Zhong Xi Yi Jie He Xue Bao. 2012 Mar;10(3):256-63. doi: 10.3736/jcim20120303. Zhong Xi Yi Jie He Xue Bao. 2012. PMID: 22409914 Review.